‘Is it better than nothing? I suppose’: Sanders disappointed by Dems’ drug pricing plan
"It's a very weak proposal" but "we're dealing with the power of PhRMA over the Congress," he said, taking aim at industry lobbyists.
Pharma mobilizes army of lobbyists to tank Democrats’ Medicare drug pricing plan
"Big Pharma is fighting hard to keep their price-setting monopoly intact," said one advocacy coalition.
US legislation to hold global shipping industry accountable for climate and air pollution introduced...
“This is a big step forward for climate smart ports and a clean energy future for every community.”
The selfish politics of anti-abortionists
Those claiming to be against abortion often rely on being able to access the procedure when they need it—a common conservative approach to social needs.
Glyphosate found in more than 80% of U.S. urine samples
Glyphosate was listed as a probable human carcinogen by the World Health Organization’s International Agency for Research on Cancer in 2015.
Under pressure to act, Biden to sign executive order on abortion access
The president's order excludes certain actions that progressives have demanded, such as authorizing the use of federal lands to set up abortion clinics in Republican-led states.
EPA likely underestimating amount of toxic forever chemicals in US water: Analysis
"The EPA is doing the bare minimum it can and that's putting people's health at risk," said the policy director of Public Employees for Environmental Responsibility.
Science shows US Supreme Court abortion, guns, environment rulings will have devastating consequences
We can’t allow ourselves to be discouraged. Too much is at stake.
US Court of Appeals overturns EPA’s decision that glyphosate is safe for humans and...
Glyphosate, the active ingredient in Monsanto-Bayer’s pesticide, is the most widely used pesticide in the world.
Bayer appeal to dismiss Roundup weedkiller lawsuits rejected by U.S. Supreme Court
Bayer said it plans to replace glyphosate-based weed-killing ingredients in products for non-professionals in the U.S. with alternative active ingredients in order to “manage litigation risk in the U.S.,” but not due to concerns about safety.